annual FCF:
$475.42M+$423.77M(+820.51%)Summary
- As of today (July 31, 2025), BMRN annual free cash flow is $475.42 million, with the most recent change of +$423.77 million (+820.51%) on December 31, 2024.
- During the last 3 years, BMRN annual FCF has risen by +$290.11 million (+156.55%).
- BMRN annual FCF is now at all-time high.
Performance
BMRN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$157.63M-$7.70M(-4.66%)Summary
- As of today (July 31, 2025), BMRN quarterly free cash flow is $157.63 million, with the most recent change of -$7.70 million (-4.66%) on March 31, 2025.
- Over the past year, BMRN quarterly FCF has increased by +$144.76 million (+1125.04%).
- BMRN quarterly FCF is now -21.31% below its all-time high of $200.31 million, reached on September 30, 2024.
Performance
BMRN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$620.18M+$144.76M(+30.45%)Summary
- As of today (July 31, 2025), BMRN TTM free cash flow is $620.18 million, with the most recent change of +$144.76 million (+30.45%) on March 31, 2025.
- Over the past year, BMRN TTM FCF has increased by +$456.97 million (+279.98%).
- BMRN TTM FCF is now at all-time high.
Performance
BMRN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BMRN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +820.5% | +1125.0% | +280.0% |
| 3 y3 years | +156.6% | +307.1% | +2489.8% |
| 5 y5 years | +512.9% | +366.2% | +1938.1% |
BMRN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +971.7% | -21.3% | +259.7% | at high | >+9999.0% |
| 5 y | 5-year | at high | +512.9% | -21.3% | +259.7% | at high | +1289.1% |
| alltime | all time | at high | +206.3% | -21.3% | +172.8% | at high | +222.8% |
BMRN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $157.63M(-4.7%) | $620.18M(+30.4%) |
| Dec 2024 | $475.42M(+820.5%) | $165.33M(-17.5%) | $475.42M(+58.0%) |
| Sep 2024 | - | $200.31M(+106.7%) | $300.88M(+41.4%) |
| Jun 2024 | - | $96.92M(+653.3%) | $212.80M(+30.4%) |
| Mar 2024 | - | $12.87M(-239.7%) | $163.21M(+216.0%) |
| Dec 2023 | $51.65M(+16.4%) | -$9.21M(-108.2%) | $51.65M(+65.1%) |
| Sep 2023 | - | $112.23M(+137.1%) | $31.29M(-23.5%) |
| Jun 2023 | - | $47.33M(-148.0%) | $40.91M(+87.9%) |
| Mar 2023 | - | -$98.70M(+233.7%) | $21.77M(-50.9%) |
| Dec 2022 | $44.36M(-76.1%) | -$29.57M(-124.3%) | $44.36M(+8.8%) |
| Sep 2022 | - | $121.85M(+332.2%) | $40.76M(-1027.5%) |
| Jun 2022 | - | $28.19M(-137.0%) | -$4.39M(-118.3%) |
| Mar 2022 | - | -$76.11M(+129.4%) | $23.95M(-87.1%) |
| Dec 2021 | $185.31M(-455.3%) | -$33.18M(-143.3%) | $185.31M(+12.1%) |
| Sep 2021 | - | $76.70M(+35.7%) | $165.24M(+6.9%) |
| Jun 2021 | - | $56.53M(-33.7%) | $154.59M(+67.5%) |
| Mar 2021 | - | $85.26M(-260.1%) | $92.31M(-277.0%) |
| Dec 2020 | -$52.15M(-54.7%) | -$53.25M(-180.6%) | -$52.15M(+2068.6%) |
| Sep 2020 | - | $66.05M(-1249.1%) | -$2.40M(-92.9%) |
| Jun 2020 | - | -$5.75M(-90.3%) | -$33.74M(-62.1%) |
| Mar 2020 | - | -$59.21M(+1592.2%) | -$89.03M(-22.7%) |
| Dec 2019 | -$115.14M(-7.4%) | -$3.50M(-110.1%) | -$115.14M(+10.3%) |
| Sep 2019 | - | $34.72M(-156.9%) | -$104.35M(-26.4%) |
| Jun 2019 | - | -$61.03M(-28.5%) | -$141.73M(+3.4%) |
| Mar 2019 | - | -$85.33M(-1269.7%) | -$137.07M(+10.2%) |
| Dec 2018 | -$124.41M(-40.2%) | $7.29M(-374.4%) | -$124.41M(-20.7%) |
| Sep 2018 | - | -$2.66M(-95.3%) | -$156.98M(-1.0%) |
| Jun 2018 | - | -$56.38M(-22.4%) | -$158.51M(+20.9%) |
| Mar 2018 | - | -$72.67M(+187.5%) | -$131.12M(-37.0%) |
| Dec 2017 | -$207.98M(-44.7%) | -$25.28M(+503.2%) | -$207.98M(-11.3%) |
| Sep 2017 | - | -$4.19M(-85.5%) | -$234.48M(-12.1%) |
| Jun 2017 | - | -$28.98M(-80.6%) | -$266.76M(-13.7%) |
| Mar 2017 | - | -$149.53M(+188.8%) | -$309.09M(-17.8%) |
| Dec 2016 | -$376.22M(-15.9%) | -$51.78M(+42.0%) | -$376.22M(-23.9%) |
| Sep 2016 | - | -$36.46M(-48.9%) | -$494.09M(-2.2%) |
| Jun 2016 | - | -$71.31M(-67.1%) | -$505.03M(+4.7%) |
| Mar 2016 | - | -$216.66M(+27.7%) | -$482.17M(+7.8%) |
| Dec 2015 | -$447.15M(+138.5%) | -$169.66M(+257.9%) | -$447.15M(+35.8%) |
| Sep 2015 | - | -$47.41M(-2.1%) | -$329.17M(+4.3%) |
| Jun 2015 | - | -$48.45M(-73.3%) | -$315.49M(-1.1%) |
| Mar 2015 | - | -$181.64M(+251.5%) | -$319.03M(+70.2%) |
| Dec 2014 | -$187.48M(+53.0%) | -$51.67M(+53.2%) | -$187.48M(+7.4%) |
| Sep 2014 | - | -$33.73M(-35.1%) | -$174.56M(+6.7%) |
| Jun 2014 | - | -$51.98M(+3.8%) | -$163.53M(+27.0%) |
| Mar 2014 | - | -$50.10M(+29.3%) | -$128.77M(+5.1%) |
| Dec 2013 | -$122.53M(+354.4%) | -$38.75M(+70.7%) | -$122.53M(+43.0%) |
| Sep 2013 | - | -$22.69M(+31.7%) | -$85.69M(+34.3%) |
| Jun 2013 | - | -$17.23M(-60.7%) | -$63.79M(+11.0%) |
| Mar 2013 | - | -$43.85M(+2197.3%) | -$57.47M(+113.1%) |
| Dec 2012 | -$26.96M(-80.1%) | -$1.91M(+138.9%) | -$26.96M(-76.6%) |
| Sep 2012 | - | -$799.00K(-92.7%) | -$115.25M(-28.8%) |
| Jun 2012 | - | -$10.90M(-18.3%) | -$161.97M(+16.2%) |
| Mar 2012 | - | -$13.35M(-85.2%) | -$139.41M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$135.80M(+342.1%) | -$90.19M(+89.8%) | -$135.80M(+88.3%) |
| Sep 2011 | - | -$47.53M(-507.7%) | -$72.13M(+189.4%) |
| Jun 2011 | - | $11.66M(-219.7%) | -$24.92M(-15.8%) |
| Mar 2011 | - | -$9.74M(-63.3%) | -$29.60M(-3.6%) |
| Dec 2010 | -$30.71M(+1384.5%) | -$26.52M(+8320.0%) | -$30.71M(+318.1%) |
| Sep 2010 | - | -$315.00K(-104.5%) | -$7.35M(+42.5%) |
| Jun 2010 | - | $6.98M(-164.3%) | -$5.16M(-63.7%) |
| Mar 2010 | - | -$10.86M(+244.2%) | -$14.21M(+586.8%) |
| Dec 2009 | -$2.07M(-96.8%) | -$3.15M(-268.3%) | -$2.07M(-72.5%) |
| Sep 2009 | - | $1.88M(-190.5%) | -$7.52M(-57.6%) |
| Jun 2009 | - | -$2.07M(-261.5%) | -$17.76M(-19.8%) |
| Mar 2009 | - | $1.28M(-114.9%) | -$22.15M(-66.2%) |
| Dec 2008 | -$65.54M(+15.2%) | -$8.61M(+3.0%) | -$65.54M(+1.1%) |
| Sep 2008 | - | -$8.36M(+29.3%) | -$64.82M(-9.8%) |
| Jun 2008 | - | -$6.46M(-84.6%) | -$71.83M(-5.0%) |
| Mar 2008 | - | -$42.11M(+433.7%) | -$75.64M(+32.9%) |
| Dec 2007 | -$56.91M(-25.9%) | -$7.89M(-48.6%) | -$56.91M(-12.5%) |
| Sep 2007 | - | -$15.36M(+49.6%) | -$65.04M(+0.5%) |
| Jun 2007 | - | -$10.27M(-56.1%) | -$64.69M(-19.0%) |
| Mar 2007 | - | -$23.38M(+45.9%) | -$79.89M(+4.1%) |
| Dec 2006 | -$76.75M(+16.9%) | -$16.02M(+6.7%) | -$76.75M(-5.0%) |
| Sep 2006 | - | -$15.02M(-41.0%) | -$80.80M(-8.6%) |
| Jun 2006 | - | -$25.46M(+25.8%) | -$88.38M(+32.1%) |
| Mar 2006 | - | -$20.24M(+0.8%) | -$66.90M(+1.9%) |
| Dec 2005 | -$65.64M(-12.6%) | -$20.08M(-11.1%) | -$65.64M(+7.5%) |
| Sep 2005 | - | -$22.59M(+468.1%) | -$61.03M(-3.1%) |
| Jun 2005 | - | -$3.98M(-79.1%) | -$63.00M(-22.0%) |
| Mar 2005 | - | -$18.98M(+22.7%) | -$80.78M(+7.5%) |
| Dec 2004 | -$75.12M(-7.0%) | -$15.48M(-37.0%) | -$75.12M(-21.7%) |
| Sep 2004 | - | -$24.56M(+12.9%) | -$95.97M(+0.1%) |
| Jun 2004 | - | -$21.76M(+63.3%) | -$95.92M(+16.8%) |
| Mar 2004 | - | -$13.33M(-63.3%) | -$82.13M(+1.7%) |
| Dec 2003 | -$80.77M(+38.2%) | -$36.32M(+48.2%) | -$80.77M(+2.1%) |
| Sep 2003 | - | -$24.50M(+207.1%) | -$79.12M(+31.3%) |
| Jun 2003 | - | -$7.98M(-33.3%) | -$60.27M(+0.7%) |
| Mar 2003 | - | -$11.97M(-65.5%) | -$59.84M(+2.4%) |
| Dec 2002 | -$58.46M(-0.4%) | -$34.67M(+513.6%) | -$58.46M(+8.0%) |
| Sep 2002 | - | -$5.65M(-25.2%) | -$54.14M(-11.1%) |
| Jun 2002 | - | -$7.55M(-28.6%) | -$60.89M(+2.1%) |
| Mar 2002 | - | -$10.58M(-65.2%) | -$59.66M(+1.7%) |
| Dec 2001 | -$58.66M(+255.7%) | -$30.36M(+144.8%) | -$58.66M(+78.8%) |
| Sep 2001 | - | -$12.40M(+96.3%) | -$32.81M(+44.2%) |
| Jun 2001 | - | -$6.32M(-34.1%) | -$22.76M(+16.0%) |
| Mar 2001 | - | -$9.58M(+112.8%) | -$19.63M(+19.0%) |
| Dec 2000 | -$16.49M(-54.0%) | -$4.50M(+91.6%) | -$16.49M(-13.1%) |
| Sep 2000 | - | -$2.35M(-26.2%) | -$18.97M(-38.0%) |
| Jun 2000 | - | -$3.19M(-50.6%) | -$30.62M(-13.6%) |
| Mar 2000 | - | -$6.45M(-7.6%) | -$35.46M(-1.2%) |
| Dec 1999 | -$35.88M(+147.5%) | -$6.98M(-50.1%) | -$35.88M(+24.2%) |
| Sep 1999 | - | -$14.00M(+74.5%) | -$28.90M(+94.0%) |
| Jun 1999 | - | -$8.02M(+16.7%) | -$14.90M(+116.7%) |
| Mar 1999 | - | -$6.88M | -$6.88M |
| Dec 1998 | -$14.50M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual free cash flow?
- What is the all time high annual FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual FCF year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly FCF year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM free cash flow?
- What is the all time high TTM FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM FCF year-on-year change?
What is BioMarin Pharmaceutical Inc. annual free cash flow?
The current annual FCF of BMRN is $475.42M
What is the all time high annual FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual free cash flow is $475.42M
What is BioMarin Pharmaceutical Inc. annual FCF year-on-year change?
Over the past year, BMRN annual free cash flow has changed by +$423.77M (+820.51%)
What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
The current quarterly FCF of BMRN is $157.63M
What is the all time high quarterly FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly free cash flow is $200.31M
What is BioMarin Pharmaceutical Inc. quarterly FCF year-on-year change?
Over the past year, BMRN quarterly free cash flow has changed by +$144.76M (+1125.04%)
What is BioMarin Pharmaceutical Inc. TTM free cash flow?
The current TTM FCF of BMRN is $620.18M
What is the all time high TTM FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM free cash flow is $620.18M
What is BioMarin Pharmaceutical Inc. TTM FCF year-on-year change?
Over the past year, BMRN TTM free cash flow has changed by +$456.97M (+279.98%)